pharmathen

BC Partners announced the sale of the majority stake in Pharmathen to the international private equity firm Partners Group. The transaction values ​​the company at 1.6 billion euros.

Pharmathen was founded in 1969 and was acquired by BC Partners in 2015 for 475 million euros and is now the leading European company in the field of drug administration technology, the announcement said.

Greek pharmaceutical industries are starting the mass production of antiseptic solution to cover the increasing needs of the country's national healthcare system fighting the new coronavirus.

The government may be rejoicing in the increase in spending on research and development, but the message from abroad points to the sluggish performance of Greek businesses in the R&D sector.

Five Greek firms rank among Europe's top 1,000 from various sectors of the economy for spending on research and development in 2017.